Gavin MacBeath

Gavin MacBeath

Chief Executive Officer at TSCAN THERAPEUTICS, INC.

Net worth: 53 748 $ as of 2026-05-30

56 year
Health Technology
Consumer Services

Profile

Gavin MacBeath was the founder of Merrimack Pharmaceuticals, Inc., founded in 1993, where the title held was Head-Translational Medicine from 2016 to 2017.
Dr. MacBeath is currently Chief Executive Officer & Director at TScan Therapeutics, Inc. since 2023, with the job starting in 2018 and continuing.
Former jobs include Chief Scientific Officer at Abpro Corp.
from 2017 to 2018 and Associate Professor at Harvard University from 2002 to 2010.
Education includes a doctorate from The Scripps Research Institute conferred in 1997 and an undergraduate degree from the University of Manitoba conferred in 1991.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 49,767 ( 0.08% ) 53 748 $ 2026-05-30

Gavin MacBeath active positions

CompaniesPositionStart
TSCAN THERAPEUTICS, INC. Chief Executive Officer 2023-03-27

Former positions of Gavin MacBeath

CompaniesPositionEnd
ABPRO CORPORATION Chief Tech/Sci/R&D Officer 2018-06-30
MERRIMACK PHARMACEUTICALS Founder 2017-08-31
Corporate Officer/Principal 2010-05-31
See the detail of Gavin MacBeath's experience

Training of Gavin MacBeath

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

86

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Gavin MacBeath
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!